|
Volumn 13, Issue 2, 1996, Pages 113-144
|
Biotechnology and the utilitarian argument for patents
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT DNA;
AGRICULTURE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
COST BENEFIT ANALYSIS;
DEVELOPING COUNTRY;
ECONOMICS;
ETHICAL THEORY;
ETHICS;
FINANCIAL MANAGEMENT;
GENE;
GENETICS;
GENETICS AND REPRODUCTION;
GOVERNMENT;
HEALTH CARE ORGANIZATION;
HUMAN;
INDUSTRY;
INFORMATION DISSEMINATION;
INFORMATION SERVICE;
MEDICAL RESEARCH;
MEDICAL TECHNOLOGY;
MOTIVATION;
PATENT;
POLICY;
RESEARCH;
RESOURCE ALLOCATION;
RISK;
RISK ASSESSMENT;
SCIENCE;
SOCIAL CHANGE;
TRANSGENIC ORGANISM;
UNITED STATES;
UNIVERSITY;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
GENETICS AND REPRODUCTION;
AGRICULTURE;
BIOMEDICAL RESEARCH;
BIOMEDICAL TECHNOLOGY;
COST-BENEFIT ANALYSIS;
DEVELOPING COUNTRIES;
DNA, RECOMBINANT;
ECONOMICS;
ETHICAL THEORY;
ETHICS;
FEDERAL GOVERNMENT;
FINANCING, GOVERNMENT;
GENES;
GENETIC RESEARCH;
GENETICS;
GOVERNMENT;
HEALTH CARE RATIONING;
HUMANS;
INDUSTRY;
INFORMATION DISSEMINATION;
INFORMATION SERVICES;
MOTIVATION;
ORGANISMS, GENETICALLY MODIFIED;
PATENTS;
PUBLIC POLICY;
RESEARCH;
RESOURCE ALLOCATION;
RISK;
RISK ASSESSMENT;
SCIENCE;
SOCIAL CHANGE;
UNITED STATES;
UNIVERSITIES;
|
EID: 0030170826
PISSN: 02650525
EISSN: None
Source Type: Journal
DOI: 10.1017/s0265052500003484 Document Type: Article |
Times cited : (20)
|
References (1)
|